114 related articles for article (PubMed ID: 17267063)
21. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
[TBL] [Abstract][Full Text] [Related]
22. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
23. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Nakabayashi H; Taketa K; Miyano K; Yamane T; Sato J
Cancer Res; 1982 Sep; 42(9):3858-63. PubMed ID: 6286115
[TBL] [Abstract][Full Text] [Related]
24. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
25. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
[TBL] [Abstract][Full Text] [Related]
26. An overview: in vitro models of HCV replication in different cell cultures.
Tariq H; Manzoor S; Parvaiz F; Javed F; Fatima K; Qadri I
Infect Genet Evol; 2012 Jan; 12(1):13-20. PubMed ID: 22061839
[TBL] [Abstract][Full Text] [Related]
27. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication.
Rakic B; Sagan SM; Noestheden M; Bélanger S; Nan X; Evans CL; Xie XS; Pezacki JP
Chem Biol; 2006 Jan; 13(1):23-30. PubMed ID: 16426968
[TBL] [Abstract][Full Text] [Related]
29. Cell culture and infection system for hepatitis C virus.
Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
[TBL] [Abstract][Full Text] [Related]
30. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
31. Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents.
Ueda Y; Mori K; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2011 Jun; 409(4):663-8. PubMed ID: 21620801
[TBL] [Abstract][Full Text] [Related]
32. Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
Valli MB; Crema A; Lanzilli G; Serafino A; Bertolini L; Ravagnan G; Ponzetto A; Menzo S; Clementi M; Carloni G
J Med Virol; 2007 Oct; 79(10):1491-9. PubMed ID: 17705190
[TBL] [Abstract][Full Text] [Related]
33. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
34. Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture.
Kato N; Abe K; Mori K; Ariumi Y; Dansako H; Ikeda M
Arch Virol; 2009; 154(1):77-85. PubMed ID: 19082684
[TBL] [Abstract][Full Text] [Related]
35. Isolation of JFH-1 strain and development of an HCV infection system.
Wakita T
Methods Mol Biol; 2009; 510():305-27. PubMed ID: 19009271
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein.
Zhang J; Yamada O; Kawagishi K; Yoshida H; Araki H; Yamaoka S; Hattori T; Shimotohno K
Virology; 2007 Dec; 369(1):198-205. PubMed ID: 17765943
[TBL] [Abstract][Full Text] [Related]
37. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
38. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
39. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
40. A highly efficient and robust in vitro translation system for expression of picornavirus and hepatitis C virus RNA genomes.
Svitkin YV; Sonenberg N
Methods Enzymol; 2007; 429():53-82. PubMed ID: 17913619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
